Current monetization status

Lab Intel is currently a public education site built for indexing, reader trust, and long-term traffic. It does not currently include display advertising, sponsored placements, affiliate links, paid rankings, lead-generation forms, checkout flows, lab-ordering flows, newsletter sponsorships, or paid product endorsements.

What should be disclosed later

If Lab Intel later earns money from a page, link, referral, comparison, sponsorship, newsletter, tool, or product relationship, that relationship should be disclosed close to the relevant content and in plain language. Readers should not have to infer whether a recommendation, placement, ranking, or link is paid.

Editorial independence

Money should not decide whether a test claim is presented as medically valid. Paid relationships should not override the source hierarchy, medical disclaimer, review-status boundary, correction policy, or privacy notice.

  • Commercial lab and test-company pages may describe what a product claims, but they should not be treated as independent medical evidence.
  • A paid link should never be presented as proof that a test is necessary, validated, accurate, or appropriate for a specific person.
  • Sponsored content should be labeled before the reader reaches the main claim, not hidden at the end of the page.
  • Product comparisons should explain selection criteria, evidence limits, and whether compensation affects inclusion or ordering.

Health privacy boundary

Monetization can create privacy risk when it touches health-adjacent searches, STI questions, genetic risk, microbiome reports, symptoms, insurance status, or lab-ordering intent. Before analytics, affiliate tracking, remarketing, lead generation, or account features are added, the privacy notice should explain what is collected, why, where it goes, how long it is kept, and whether vendors receive sensitive context.

What monetization cannot do

  • It cannot create a clinician-patient relationship.
  • It cannot turn general education into personal medical advice.
  • It cannot decide whether a specific reader needs a test, treatment, medication change, or urgent care.
  • It cannot remove source caveats because they make a product less attractive.
  • It cannot collect personal health information without an explicit, secure, and disclosed intake path.

Before monetization launches

Before monetized features are added, Lab Intel should publish or update the relevant disclosure, privacy, contact, correction, and review-status pages. A working correction or editorial contact path should be available before sponsored pages, product comparisons, affiliate links, referrals, or lead generation go live.

Reader rule of thumb

If Lab Intel eventually links to a lab, test, product, service, marketplace, coupon, or referral path, treat that as a convenience or commercial path, not as a medical instruction. Use clinicians, public-health clinics, laboratories, genetic counselors, or emergency services for personal decisions.